Changes

*Microsystems technologies are changing the Life Sciences industry. New in vitro diagnostic systems, new therapy strategies, genetic diseases treatment, targeted and intelligent drug delivery, artificial pancreas, drug discovery processes are health improvement promised to the future generations, enabled by semiconductor and MEMS technologies. The Life Sciences industry already faces critical challenges to take its way to its expected market.

*The bar graph below gives details of the MEMS component for lifescience market

*Micro- and nano-electromechanical systems (MEMS or NEMS)-based drug delivery devices offer opportunities to address unmet medical needs related to dosing. Such devices should be considered when conventional dosing methods perform suboptimally in terms of safety, efficacy, pain, or convenience. In addition, applications of these technologies may create totally new drug delivery paradigms. MEMS technologies may create new therapies with existing molecular entities.